TMCnet News

ReportsnReports.com: Global Macular Edema Market to Grow at 9.1% CAGR by 2018
[August 01, 2014]

ReportsnReports.com: Global Macular Edema Market to Grow at 9.1% CAGR by 2018


(M2 PressWIRE Via Acquire Media NewsEdge) ReportsnReports.com offers "Global Macular Edema Market 2014-2018" research report in its store. Macular edema results from fluid accumulation in the macular region of the retina. Macular edema arises from various etiologies such as diabetes, AMD, and RVO. Macular edema disrupts the central vision due to swelling of the macula. Currently, the treatment plan involves the use of surgical and laser therapies as well as drugs such as anti-VEGF therapies and NSAIDs. Surgery and laser therapy are intended to prevent further damage to vision. However, anti-VEGF therapies have been reported to improve the vision loss associated with macular edema.



Browse the Reports @ http://www.reportsnreports.com/reports/291960-global-macular-edema-market-2014-2018-.html.

Analysts forecast the Global Macular Edema market will grow at a CAGR of 9.1 percent over the period 2014-2018.


Covered in this Report This report covers the present scenario and the growth prospects of the Global Macular Edema market for the period 2013-2018. To calculate the market size, the report considers revenue generated through the sales of various drugs administered to treat macular edema associated with distinct etiologies.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Macular Edema market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

Global Macular Edema Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Macular Edema market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions o Americas o EMEA o APAC Key Vendors o Bayer AG o F. Hoffmann-La Roche Ltd.

o Novartis AG o Regeneron Pharmaceuticals Inc.

Purchase Report @ http://www.reportsnreports.com/Purchase.aspx?name=291960.

Other Prominent Vendors o Alcon Inc.

o Alimera Sciences Inc.

o Allergan Inc.

o Ampio Pharmaceuticals Inc.

o iCo Therapeutics Inc.

o Pfizer Inc.

o Santen Pharmaceutical Co. Ltd.

Key Market Driver o Increase in Patient Population Key Market Challenge o Increasing Use of Off-label Drugs Key Market Trend o Increasing Recommendations by NICE Key Questions Answered in this Report o What will the market size be in 2018 and what will the growth rate be? o What are the key market trends? o What is driving this market? o What are the challenges to market growth? o Who are the key vendors in this market space? o What are the market opportunities and threats faced by the key vendors? o What are the strengths and weaknesses of the key vendors? About Us: ReportsnReports.com is an online market research reports (http://www.reportsnreports.com/ ) library of 400,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on [email protected] and we would be happy to help you find the business intelligence that you need. Not limited to a particular industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, consumer goods, environment, pharmaceuticals, healthcare, food and beverages, biotechnology, retail, water, advanced materials and much more.

CONTACT: Ritesh Tiwari [email protected] +1 888 391 5441 https://www.facebook.com/pages/ReportsnReports/191441427571689 https://www.linkedin.com/company/reportsnreports https://twitter.com/marketsreports https://www.pinterest.com/comeonseo/rep .

(c) 2014 M2 COMMUNICATIONS

[ Back To TMCnet.com's Homepage ]